Browse By Region

Browse By Category
Recent News
By Category: Agents & Toxins
How Ebola sneaks past immune system
(Futurity) Ebola virus is the causative agent of Ebola Hemorrhagic Fever (EHF), a disease with up to 90 percent mortality. While human outbreaks of Ebola hemorrhagic fever have been confined to Africa, Ebola virus infections in bats, the presumed natural reservoir of the virus, have also been detected in Europe and Asia. Ebola virus infection Read More »
- December 18, 2012
- | Filed under Africa, North America, Agents & Toxins, International, Public Health, and Research
FDA approves raxibacumab to treat inhalational anthrax
(FDA) The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus anthracis. Raxibacumab also is approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate. Raxibacumab is a monoclonal antibody that Read More »
- December 17, 2012
- | Filed under North America, Agents & Toxins, Countermeasures, and Public Health
With new rules, few public health labs to handle riskiest agents
(CIDRAP) With tougher security requirements set to take effect next April, few state public health laboratories plan to maintain stocks of certain pathogens considered most tempting to bioterrorists, according to the Association of Public Health Laboratories (APHL) and officials with state labs. Pathogens such as Bacillus anthracis, Ebola virus, and several others have been designated Read More »
- December 14, 2012
- | Filed under North America, Agents & Toxins, Policy & Initiatives, Public Health, and Research
Ebola virus uses a protein decoy to subvert the host immune response
(EurekAlert) In a study published today in the Open Access journal PLOS Pathogens, researchers at Emory University have discovered a potentially important mechanism by which the Ebola virus alters and evades the immune response of its infected host. Ebola virus is the causative agent of Ebola Hemorrhagic Fever (EHF), a disease with up to 90 Read More »
- December 14, 2012
- | Filed under Africa, North America, Agents & Toxins, International, Public Health, and Research
Gene-altered mosquitoes could be used vs. dengue
(Southeast Missourian) Mosquito control officials in the Florida Keys are waiting for the federal government to sign off on an experiment that would release hundreds of thousands of genetically modified mosquitoes to reduce the risk of dengue fever in the tourist town of Key West. If approved by the Food and Drug Administration, it would Read More »
- December 13, 2012
- | Filed under Europe, North America, Agents & Toxins, Public Health, and Research